Coverage
-
June 15, 2023
Investors in biotechnology firm Inovio Pharmaceuticals Inc. have received an initial green light from a Philadelphia federal judge for their agreement to settle their derivative action against the company's brass over alleged misrepresentations about the company's efforts to produce a vaccine for COVID-19 in a matter of hours.
3 other articles on this case.
View all »